Engineered Probiotics Protect against Pseudomonas aeruginosa Post Antibiotic Exposure

Siyao Wang1,2, Baoyan Zhang1,2, Shuyi Zhang3,4

  • 1Beijing Advanced Innovation Centre for Biomedical Engineering, Key Laboratory for Biomechanics and Mechanobiology of Ministry of Education, School of Engineering Medicine, Beihang University, Beijing 100083, P. R. China.

ACS Synthetic Biology
|June 10, 2026
PubMed

Insights

Engineered probiotics can restore gut microbiota and immunity after antibiotics. This strategy combines metabolite replenishment and targeted immunization to combat opportunistic infections like Pseudomonas aeruginosa.

Area of Science:

  • Microbiology
  • Immunology
  • Synthetic Biology

Background:

  • Broad-spectrum antibiotics disrupt gut microbiota and mucosal immunity, increasing susceptibility to opportunistic pathogens like Pseudomonas aeruginosa.
  • Limited strategies exist to restore host homeostasis and mucosal immunity during the vulnerable postantibiotic period.

Purpose of the Study:

  • To develop a modular probiotic strategy using engineered Escherichia coli Nissle 1917 (EcN) for metabolite replenishment and antigen-specific mucosal immunization.
  • To evaluate the efficacy of this strategy in restoring immune homeostasis and preventing opportunistic infections post-antibiotic treatment.

Main Methods:

  • Engineered EcN strains to overproduce butyrate for immune restoration.
  • Engineered EcN strains to display Pseudomonas aeruginosa antigens (PcrV or OprL) on outer-membrane vesicles for immunization.
  • Administered engineered EcN strains to antibiotic-exposed mice and challenged with P. aeruginosa.

Main Results:

  • The butyrate-producing EcN restored immune homeostasis, increased pulmonary neutrophils, and enhanced bacterial clearance.
  • Antigen-displaying EcN elicited pathogen-specific mucosal immunity.
  • Both metabolite and immunization modules independently reduced bacterial burden and improved survival; combined administration showed synergistic protection.

Conclusions:

  • A versatile synthetic biology framework using modular engineered probiotics offers a promising approach to combat opportunistic infections.
  • This strategy integrates metabolite replenishment and targeted immunotherapy for enhanced protection against postantibiotic infections.
  • Flexible combination of probiotic modules provides a novel alternative to conventional antibiotic-dependent infection control.

Related Concept Videos

Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...